UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease

Gut, 2000-09, Vol.47 (3), p.397-403

2000

Volltextzugriff (PDF)

Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

Oncogene, 2011-06, Vol.30 (23), p.2622-2632

2011

Volltextzugriff (PDF)

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

Targeted oncology, 2012-03, Vol.7 (1), p.3-14

2012

Volltextzugriff (PDF)

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition

PLoS pathogens, 2018-04, Vol.14 (4), p.e1007041-e1007041

2018

Volltextzugriff (PDF)

Cellules dendritiques et mélanome

Oncologie (Paris, France), 2001, Vol.3 (8), p.371-377

2001

Volltextzugriff (PDF)

Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptides

Immunology, 1997-08, Vol.91 (4), p.635-642

1997

Volltextzugriff (PDF)

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1750-1758

1998

Volltextzugriff (PDF)

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility? : IMMUNOTHERAPY

Targeted oncology, 2012, Vol.7 (1), p.3-14

2012

Volltextzugriff (PDF)

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

The Journal of experimental medicine, 1996-05, Vol.183 (5), p.2403-2407

1996

Volltextzugriff (PDF)

PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting

Cancer Immunology, Immunotherapy, 2008-02, Vol.57 (2), p.185-195

2008

Volltextzugriff (PDF)

Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases

European journal of immunology, 1998-01, Vol.28 (1), p.264-276

1998

Volltextzugriff (PDF)

Synthetic Anticancer Vaccine Candidates: Rational Design of Antigenic Peptide Mimetics That Activate Tumor-Specific T-Cells

Journal of medicinal chemistry, 2007-04, Vol.50 (7), p.1598-1609

2007

Volltextzugriff (PDF)

Dominant TCR Vα usage by virus and tumor‐reactive T cells with wide affinity ranges for their specific antigens

European journal of immunology, 2002-11, Vol.32 (11), p.3181-3190

2002

Volltextzugriff (PDF)

Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy

The Journal of immunology (1950), 2002-05, Vol.168 (10), p.4864-4870

2002

Volltextzugriff (PDF)

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

Cancer Immunology, Immunotherapy, 2002-11, Vol.51 (10), p.532-538

2002

Volltextzugriff (PDF)

Cytolytic T lymphocyte recognition of the immunodominant HLA-A0201-restricted Melan-A/MART-1 antigenic peptide in melanoma

The Journal of immunology (1950), 1997-09, Vol.159 (5), p.2366-2374

1997

Volltextzugriff (PDF)

T cell activation by antigens on human melanoma cells—co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro

International immunology, 1995-10, Vol.7 (10), p.1535-1543

1995

Volltextzugriff (PDF)

Apoptotic body–loaded dendritic cells efficiently cross‐prime cytotoxic T lymphocytes specific for NA17‐A antigen but not for Melan‐A/MART‐1 antigen

Cancer Immunology, Immunotherapy, 2002-09, Vol.101 (3), p.280-286

2002

Volltextzugriff (PDF)

High Avidity Melanoma-reactive Cytotoxic T Lymphocytes Are Efficiently Induced from Peripheral Blood Lymphocytes on Stimulation by Peptide-pulsed Melanoma Cells

Clinical cancer research, 2000-04, Vol.6 (4), p.1459-1467

2000

Volltextzugriff (PDF)

Diversity of the Fine Specificity Displayed by HLA-A0201-Restricted CTL Specific for the Immunodominant Melan-A/MART-1 Antigenic Peptide

The Journal of immunology (1950), 1998-12, Vol.161 (12), p.6956-6962

1998

Volltextzugriff (PDF)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues

International immunology, 1999-12, Vol.11 (12), p.1971-1980

1999

Volltextzugriff (PDF)

Covalent modification of a melanoma-derived antigemc peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies

Molecular bioSystems, 2006-01, Vol.2 (5), p.240-249

2006

Volltextzugriff (PDF)

Heterogeneity of biologic responses of melanoma-specific CTL

The Journal of immunology (1950), 1997-09, Vol.159 (6), p.2831-2839

1997

Volltextzugriff (PDF)

Defective lymphokine production by most CD8+ and CD4+ tumor‐specific T cell clones derived from human melanoma‐infiltrating lymphocytes in response to autologous tumor cells in vitro

European journal of immunology, 1994-09, Vol.24 (9), p.1966-1973

1994

Volltextzugriff (PDF)

Passive immunotherapy of melanoma

Bulletin du cancer, 2003-07, Vol.90 (7), p.583

2003

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(62)
Französisch
(58)

Erscheinungsjahr

n.n

Thema

Humans
(71)
Science & Technology
(42)
Life Sciences & Biomedicine
(39)
Life Sciences
(27)
Immunology
(21)
Melanoma - Immunology
(20)
Animals
(18)
Adult
(16)
Bcg Vaccine
(16)
Biological And Medical Sciences
(15)
Child
(15)
France
(15)
T-Lymphocytes, Cytotoxic - Immunology
(14)
Adolescent
(12)
Old Medline
(12)
Tumor Cells, Cultured
(12)
Antigens, Neoplasm - Immunology
(11)
Neoplasm Proteins - Immunology
(11)
Tuberculin Test
(11)
Child, Preschool
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease

Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition

Cellules dendritiques et mélanome

Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptides

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility? : IMMUNOTHERAPY

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting

Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases

Synthetic Anticancer Vaccine Candidates: Rational Design of Antigenic Peptide Mimetics That Activate Tumor-Specific T-Cells

Dominant TCR Vα usage by virus and tumor‐reactive T cells with wide affinity ranges for their specific antigens

Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

Cytolytic T lymphocyte recognition of the immunodominant HLA-A0201-restricted Melan-A/MART-1 antigenic peptide in melanoma

T cell activation by antigens on human melanoma cells—co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro

Apoptotic body–loaded dendritic cells efficiently cross‐prime cytotoxic T lymphocytes specific for NA17‐A antigen but not for Melan‐A/MART‐1 antigen

High Avidity Melanoma-reactive Cytotoxic T Lymphocytes Are Efficiently Induced from Peripheral Blood Lymphocytes on Stimulation by Peptide-pulsed Melanoma Cells

Diversity of the Fine Specificity Displayed by HLA-A0201-Restricted CTL Specific for the Immunodominant Melan-A/MART-1 Antigenic Peptide

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues

Covalent modification of a melanoma-derived antigemc peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies

Heterogeneity of biologic responses of melanoma-specific CTL

Defective lymphokine production by most CD8+ and CD4+ tumor‐specific T cell clones derived from human melanoma‐infiltrating lymphocytes in response to autologous tumor cells in vitro

Passive immunotherapy of melanoma

Suchergebnisse filtern